Among the pathways identified as enriched (Fig. 3c and d), the MAPK, PI3K, and Wnt pathways were enriched in both CSK- and PTEN-null GC cells (> 1.5-fold enrichment), suggesting that these pathways play important roles in lapatinib resistance. Here, PIK3CG is linked to gastric cancer.